Floatz logo

CISATRACURIUM ION

Intracranial Hypertension

University Hospital, Clermont-FerrandSmall moleculePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Intracranial Hypertension cohort.

Asset / SponsorPhaseRating
MANNITOL
University Hospital, Grenoble
Phase 4BB
Bxcl501
Henry M. Jackson Foundation for the Advancement of Military Medicine
Phase 4BB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Henry M. Jackson Foundation for the Advancement of Military Medicine
Phase 4BB
Lorazepam
Henry M. Jackson Foundation for the Advancement of Military Medicine
Phase 4BB
FENTANYL
Henry M. Jackson Foundation for the Advancement of Military Medicine
Phase 4BB

View all 11 →

Same molecule, other indications

CISATRACURIUM ION is also rated in:

Anesthesia, LocalDormant
BBB
Indicative ·
73 / 100
View asset →
Arrhythmia, CardiacDormant
BB
Indicative ·
69 / 100
View asset →
Pain, AcuteDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →